Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.

Morozova O, Vojvodic M, Grinshtein N, Hansford LM, Blakely KM, Maslova A, Hirst M, Cezard T, Morin RD, Moore R, Smith KM, Miller F, Taylor P, Thiessen N, Varhol R, Zhao Y, Jones S, Moffat J, Kislinger T, Moran MF, Kaplan DR, Marra MA.

Clin Cancer Res. 2010 Sep 15;16(18):4572-82. doi: 10.1158/1078-0432.CCR-10-0627. Epub 2010 Jul 22. Erratum in: Clin Cancer Res. 2010 Dec 1;16(23):5914.

PMID:
20651058
[PubMed - indexed for MEDLINE]
Free Article
2.

Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells.

Grinshtein N, Datti A, Fujitani M, Uehling D, Prakesch M, Isaac M, Irwin MS, Wrana JL, Al-Awar R, Kaplan DR.

Cancer Res. 2011 Feb 15;71(4):1385-95. doi: 10.1158/0008-5472.CAN-10-2484. Epub 2011 Feb 8.

PMID:
21303981
[PubMed - indexed for MEDLINE]
Free Article
3.

Targeting cell division cycle 7 kinase: a new approach for cancer therapy.

Montagnoli A, Moll J, Colotta F.

Clin Cancer Res. 2010 Sep 15;16(18):4503-8. doi: 10.1158/1078-0432.CCR-10-0185. Epub 2010 Jul 20. Review.

PMID:
20647475
[PubMed - indexed for MEDLINE]
Free Article
4.

Target validation and biomarker identification in oncology : the example of aurora kinases.

Colombo R, Moll J.

Mol Diagn Ther. 2008;12(2):71-6. Review.

PMID:
18422371
[PubMed - indexed for MEDLINE]
5.

Molecularly guided therapy of neuroblastoma: a review of different approaches.

Tonini GP, Pistoia V.

Curr Pharm Des. 2006;12(18):2303-17. Review.

PMID:
16787256
[PubMed - indexed for MEDLINE]
6.

Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.

Beppu K, Nakamura K, Linehan WM, Rapisarda A, Thiele CJ.

Cancer Res. 2005 Jun 1;65(11):4775-81.

PMID:
15930297
[PubMed - indexed for MEDLINE]
Free Article
7.

Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.

Sandoval JA, Eppstein AC, Hoelz DJ, Klein PJ, Linebarger JH, Turner KE, Rescorla FJ, Hickey RJ, Malkas LH, Schmidt CM.

J Surg Res. 2006 Jul;134(1):61-7. Epub 2006 May 2.

PMID:
16650873
[PubMed - indexed for MEDLINE]
8.

Genes involved in regulation of stem cell properties: studies on their expression in a small cohort of neuroblastoma patients.

Melone MA, Giuliano M, Squillaro T, Alessio N, Casale F, Mattioli E, Cipollaro M, Giordano A, Galderisi U.

Cancer Biol Ther. 2009 Jul;8(13):1300-6.

PMID:
19458492
[PubMed - indexed for MEDLINE]
Free Article
9.

Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.

Van Maerken T, Ferdinande L, Taildeman J, Lambertz I, Yigit N, Vercruysse L, Rihani A, Michaelis M, Cinatl J Jr, Cuvelier CA, Marine JC, De Paepe A, Bracke M, Speleman F, Vandesompele J.

J Natl Cancer Inst. 2009 Nov 18;101(22):1562-74. doi: 10.1093/jnci/djp355. Epub 2009 Nov 10.

PMID:
19903807
[PubMed - indexed for MEDLINE]
Free Article
10.

Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma.

Takita J, Ishii M, Tsutsumi S, Tanaka Y, Kato K, Toyoda Y, Hanada R, Yamamoto K, Hayashi Y, Aburatani H.

Genes Chromosomes Cancer. 2004 Jun;40(2):120-32.

PMID:
15101045
[PubMed - indexed for MEDLINE]
11.

Distinct role of ShcC docking protein in the differentiation of neuroblastoma.

Miyake I, Ohira M, Nakagawara A, Sakai R.

Oncogene. 2009 Feb 5;28(5):662-73. doi: 10.1038/onc.2008.413. Epub 2008 Nov 10.

PMID:
18997821
[PubMed - indexed for MEDLINE]
12.

Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines.

Schiapparelli P, Enguita-Germán M, Balbuena J, Rey JA, Lázcoz P, Castresana JS.

Oncol Rep. 2010 Nov;24(5):1355-62.

PMID:
20878131
[PubMed - indexed for MEDLINE]
13.

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.

Pickard MR, Green AR, Ellis IO, Caldas C, Hedge VL, Mourtada-Maarabouni M, Williams GT.

Breast Cancer Res. 2009;11(4):R60. doi: 10.1186/bcr2350. Epub 2009 Aug 11.

PMID:
19671159
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Pharmacotherapy of neuroblastoma.

George RE, Diller L, Bernstein ML.

Expert Opin Pharmacother. 2010 Jun;11(9):1467-78. doi: 10.1517/14656566.2010.482100. Review.

PMID:
20408767
[PubMed - indexed for MEDLINE]
15.

Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens.

Smith KM, Datti A, Fujitani M, Grinshtein N, Zhang L, Morozova O, Blakely KM, Rotenberg SA, Hansford LM, Miller FD, Yeger H, Irwin MS, Moffat J, Marra MA, Baruchel S, Wrana JL, Kaplan DR.

EMBO Mol Med. 2010 Sep;2(9):371-84. doi: 10.1002/emmm.201000093.

PMID:
20721990
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.

Kotchetkov R, Cinatl J, Blaheta R, Vogel JU, Karaskova J, Squire J, Hernáiz Driever P, Klingebiel T, Cinatl J Jr.

Int J Cancer. 2003 Mar 10;104(1):36-43.

PMID:
12532417
[PubMed - indexed for MEDLINE]
17.

Global genomic and RNA profiles for novel risk stratification of neuroblastoma.

Ohira M, Nakagawara A.

Cancer Sci. 2010 Nov;101(11):2295-301. doi: 10.1111/j.1349-7006.2010.01681.x. Review.

PMID:
20731666
[PubMed - indexed for MEDLINE]
18.

Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.

Ora I, Bondesson L, Jönsson C, Ljungberg J, Pörn-Ares I, Garwicz S, Pâhlman S.

Biochem Biophys Res Commun. 2000 Oct 14;277(1):179-85.

PMID:
11027660
[PubMed - indexed for MEDLINE]
19.

The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73.

Peirce SK, Findley HW.

Int J Oncol. 2009 May;34(5):1395-402.

PMID:
19360352
[PubMed - indexed for MEDLINE]
20.

BBC3 mediates fenretinide-induced cell death in neuroblastoma.

Wei JS, Whiteford CC, Cenacchi N, Son CG, Khan J.

Oncogene. 2005 Dec 1;24(54):7976-83.

PMID:
16091745
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk